When used for good, technology can be life-changing! According to NPR, the first sickle cell patient to be treated with CRISPR gene editing is still thriving nearly a year following her trial of the experimental treatment. “I’m doing great,” shared 36-year-old Victoria Gray in an interview of an update of her status since undergoing the treatments. Thanks to the technology that genetically modified her blood cells to keep them working, Gray is now free from complications that have taken over her life since birth.
Jan 4, 2022